Vusion Breaks “Not Approvable” Barrier With Dermatitis NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Barrier Therapeutics receives FDA approval for the antifungal ointment after submitting a complete response to a May 2005 “not-approvable” letter.